Recruiting
Phase 1

Gilteritinib for the Treatment of ALK NSCLC

Sponsor:

University of Michigan Rogel Cancer Center

Code:

NCT06225427

Conditions

Lung Non-Small Cell Carcinoma

Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Biospecimen Collection

Computed Tomography

Echocardiography

Gilteritinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information